Showing results (281-290 of 2,902) with videos related to
Sort By:
Pageof 291
Cancer Gene Therapy|August 11, 2001
Efficacy of the bystander effect in the herpes simplex virus thymidine kinase-mediated gene therapy is influenced by the expression of connexin43 in the target cellsH Namba, Y Iwadate, K Kawamura, et al.Cancer Gene Therapy|August 11, 2001
Induction of antitumor immunity by transduction of CD40 ligand gene and interferon-gamma gene into lung cancerM Noguchi, K Imaizumi, T Kawabe, et al.Cancer Gene Therapy|August 11, 2001
Effects of adenoviral wild-type p53 gene transfer in p53-mutated lymphoma cellsP Buttgereit, F Schakowski, A Märten, et al.Cancer Gene Therapy|August 11, 2001
Modulation of cyclophosphamide-based cytochrome P450 gene therapy using liver P450 inhibitorsZ Huang, D J WaxmanCancer Gene Therapy|August 11, 2001
Autocrine expression of both endostatin and green fluorescent protein provides a synergistic antitumor effect in a murine neuroblastoma modelA M Davidoff, M A Leary, C Y Ng, et al.Cancer Gene Therapy|September 26, 2001
Adenovirus-mediated gene transfer to orthotopic hepatocellular carcinomas in athymic nude miceS K Yoon, D Armentano, J R Wands, et al.Cancer Gene Therapy|September 26, 2001
Adenovirus-mediated expression of HSV1-TK or Fas ligand induces cell death in primary human glioma-derived cell cultures that are resistant to the chemotherapeutic agent CCNUT C Maleniak, J L Darling, P R Lowenstein, et al.Cancer Gene Therapy|December 29, 2000
Construction and characterization of DNA vaccines encoding the single-chain variable fragment of the anti-idiotype antibody 1A7 mimicking the tumor-associated antigen disialoganglioside GD2H E Zeytin, P K Tripathi, M Bhattacharya-Chatterjee, et al.Cancer Gene Therapy|December 29, 2000
Induction of antitumor immunity by combined immunogene therapy using IL-2 and IL-12 in low antigenic Lewis lung carcinomaM Tanaka, Y Saijo, G Sato, et al.Cancer Gene Therapy|March 1, 1994
Local IL-4 delivery enhances immune reactivity to murine tumors: gene therapy in combination with IL-2B A Pippin, M Rosenstein, W F Jacob, et al.Pageof 291